• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Studies on the prolonged bleeding time in von Willebrand's disease.

作者信息

Mannucci P M, Pareti F I, Holmberg L, Nilsson I M, Ruggeri Z M

出版信息

J Lab Clin Med. 1976 Oct;88(4):662-71.

PMID:787458
Abstract

Three experimental models have been employed to investigate the mechanism of the prolonged bleeding time in patients with von Willebrand's disease (vWd). 1-deamino-8-D-arginine vasopressin (DDAVP), a synthetic analogue of the antidiuretic hormone, was administered to normal volunteers and patients with vWd in order to induce a short-term, endogenous increase of factor VIII procoagulant activity (VIIIAHF), factor VIII-related antigen (VIIIAGN), and Willebrand factor (VIIIVWF); and to investigate the relationship between bleeding time and plasma variations of factor VIII-associated properties. In normal subjects DDAVP administration was followed by a marked increase of VIIIAHF, VIIIAGN, and VIIIVWF; yet the bleeding time remained unchanged. The same parameters were also raised in two groups of patients with vWd. In a third group of patients with severe recessive vWd, factor VIII-associated properties, which were not measurable before the infusion, were unmodified. The bleeding time remained unchanged in all vWd patients. To investigate the effect of the exogenous increase of factor VIII-associated properties, cryoprecipitate was given to ten vWd patients before dental surgery. Despite the marked increase of VIIAHF, VIIAGN, and VIIVWF observed after the infusion, bleeding time was not shortened. Finally, in order to evaluate the hypothesis that factor VIII may exert its effect on primary hemostasis locally in the vessel wall, VIIIAGN and its relationship with the bleeding time were studied by direct immunofluorescence in gum-biopsy specimens obtained in vWd patients before cryoprecipitate infusion. No reaction could be elicited in five patients with severe, recessive vWd, whereas venules and arterioles stained positively in five patients with a moderate form of the disease. Immunofluorescence microscopy was also carried out in specimens obtained after cryoprecipitate at a time when the plasma defects were corrected but the long bleeding time was not modified; no reaction was detectable on the vessel wall of the three patients who were negative before the infusion.

摘要

相似文献

1
Studies on the prolonged bleeding time in von Willebrand's disease.
J Lab Clin Med. 1976 Oct;88(4):662-71.
2
Intravenous DDAVP and factor VIII-von Willebrand factor concentrate for the treatment and prophylaxis of bleedings in patients With von Willebrand disease type 1, 2 and 3.静脉注射去氨加压素和因子VIII-血管性血友病因子浓缩物用于治疗和预防1型、2型和3型血管性血友病患者的出血。
Clin Appl Thromb Hemost. 2007 Jan;13(1):14-34. doi: 10.1177/1076029606296399.
3
Von Willebrand's disease in the year 2003: towards the complete identification of gene defects for correct diagnosis and treatment.2003年的血管性血友病:迈向全面鉴定基因缺陷以实现正确诊断和治疗
Haematologica. 2003 Jan;88(1):94-108.
4
A perspective on the use of FVIII concentrates and cryoprecipitate prophylactically in surgery or therapeutically in severe bleeds in patients with von Willebrand disease unresponsive to DDAVP: results of an international survey. On behalf of the Subcommittee on von Willebrand Factor of the Scientific and Standardization Committee of the ISTH.关于在对去氨加压素无反应的血管性血友病患者中预防性使用FVIII浓缩物和冷沉淀用于手术或治疗严重出血的观点:一项国际调查结果。代表国际血栓与止血学会科学和标准化委员会血管性血友病因子小组委员会。
Thromb Haemost. 1995 Nov;74(5):1370-8.
5
[Von Willebrand's disease].[血管性血友病]
Schweiz Med Wochenschr. 1987 Nov 14;117(46):1798-806.
6
A new variant of von Willebrand's disease (type I Padua): doublet-organized plasma von Willebrand factor oligomers in the presence of all size multimers.血管性血友病的一种新变体(帕多瓦I型):在所有大小的多聚体存在下,由双重结构组成的血浆血管性血友病因子寡聚体
Haematologia (Budap). 1994;26(2):97-109.
7
Evaluation of desmopressin effects on haemostasis in children with congenital bleeding disorders.去氨加压素对先天性出血性疾病患儿止血作用的评估。
Haemophilia. 2008 May;14(3):524-30. doi: 10.1111/j.1365-2516.2008.01672.x. Epub 2008 Feb 18.
8
Effect of cryoprecipitate and plasma on plasma von Willebrand factor multimeters and bleeding time in Doberman Pinschers with type-I von Willebrand's disease.冷沉淀和血浆对患有I型血管性血友病的杜宾犬血浆血管性血友病因子多聚体及出血时间的影响
Am J Vet Res. 1994 Jan;55(1):102-10.
9
Discrepant increase in factor VIII: C and von Willebrand factor after DDAVP infusion in a patient with variant von Willebrand's disease.1-去氨基-8-D-精氨酸加压素输注后,一名血管性血友病变异型患者的凝血因子VIII:C和血管性血友病因子出现差异增加。
Blood Coagul Fibrinolysis. 1991 Aug;2(4):567-73.
10
Quantitative assay of a plasma factor deficient in von Willebrand's disease that is necessary for platelet aggregation. Relationship to factor VIII procoagulant activity and antigen content.对血管性血友病中缺乏的、血小板聚集所必需的一种血浆因子进行定量测定。与凝血因子VIII促凝活性及抗原含量的关系。
J Clin Invest. 1973 Nov;52(11):2708-16. doi: 10.1172/JCI107465.

引用本文的文献

1
Angiodysplasia in von Willebrand Disease: Understanding the Clinical and Basic Science.血管发育不良在 von Willebrand 病中的表现:临床与基础科学的认识。
Semin Thromb Hemost. 2017 Sep;43(6):572-580. doi: 10.1055/s-0037-1599145. Epub 2017 May 5.
2
Factor VIII complex in uraemia and effects of haemodialysis.尿毒症中的凝血因子 VIII 复合物及血液透析的影响
Br Med J (Clin Res Ed). 1981 May 23;282(6277):1653-6. doi: 10.1136/bmj.282.6277.1653.
3
Pharmacokinetics and haematological effects of desmopressin.
Eur J Clin Pharmacol. 1988;35(3):281-5. doi: 10.1007/BF00558266.
4
Vascular damage and factor-VIII-related antigen in the rheumatic diseases.风湿性疾病中的血管损伤与因子VIII相关抗原
Rheumatol Int. 1987;7(3):107-11. doi: 10.1007/BF00270462.
5
Transplantation of normal bone marrow into a pig with severe von Willebrand's disease.将正常骨髓移植到患有严重血管性血友病的猪体内。
J Clin Invest. 1986 Jul;78(1):26-30. doi: 10.1172/JCI112560.
6
Survival of 125iodine-labeled Factor VIII in normals and patients with classic hemophilia. Observations on the heterogeneity of human Factor VIII.125碘标记的凝血因子VIII在正常人和典型血友病患者体内的存活情况。关于人凝血因子VIII异质性的观察。
J Clin Invest. 1978 Aug;62(2):223-34. doi: 10.1172/JCI109120.
7
Bleeding in renal failure: is von Willebrand factor implicated?肾衰竭中的出血:血管性血友病因子是否与之有关?
Br Med J. 1977 Aug 6;2(6083):359-61. doi: 10.1136/bmj.2.6083.359.